⌘K
Loading ticker…
As of 2026-08-24, Tenet Healthcare Corporation New (THC) has a 3-month relative strength percentile of 95 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 65. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 3.2%, relative volume 0.78×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
THC is in a stage 2 uptrend, week 2. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 25.5% / 35.8%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
THC is held by 43 ETFs as of May 2026. Top owner: VHT at 0.24% weight, $46M notional. Top 3 carry $113M.
Held by 184 ETFs · $3.2B across latest filings · largest weight 3.65% (CCFE).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VHTVanguard Health Care ETF | 0.24% | $46M | −0.07 pp |
| SCHMSchwab U.S. Mid-Cap ETF | 0.29% | $42M | −0.13 pp |
| IVOO | 0.44% | $25M | −0.17 pp |
| SCHXSchwab U.S. Large-Cap ETF | 0.02% | $16M | −0.01 pp |
| IVOG | 0.84% | $15M |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| −0.33 pp |
| GSLC | 0.08% | $13M | +0.02 pp |
| FNDXSchwab Fundamental U.S. Large Company Index ETF | 0.04% | $11M | −0.02 pp |
| VONVVanguard Russell 1000 Value ETF | 0.05% | $10M | −0.02 pp |
| SCHBSchwab U.S. Broad Market ETF | 0.02% | $9M | −0.01 pp |
| SCHVSchwab U.S. Large-Cap Value ETF | 0.05% | $8M | −0.02 pp |
Showing 10 of 43 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | THC Jan avg: 7.19% median: 10.55% win: 75% σ: 8.06% n: 4 2022-04-12 → 2026-07-31 | THC Feb avg: 8.86% median: 9.55% win: 75% σ: 15.15% n: 4 2022-04-12 → 2026-07-31 | THC Mar avg: -0.10% median: 3.89% win: 75% σ: 14.82% n: 4 2022-04-12 → 2026-07-31 | THC Apr avg: 3.52% median: 6.28% win: 60% σ: 13.89% n: 5 2022-04-12 → 2026-07-31 | THC May avg: 4.76% median: -1.02% win: 40% σ: 13.74% n: 5 2022-04-12 → 2026-07-31 | THC Jun avg: 0.98% median: 4.28% win: 60% σ: 12.43% n: 5 2022-04-12 → 2026-07-31 | THC Jul avg: 11.60% median: 12.53% win: 60% σ: 19.98% n: 5 2022-04-12 → 2026-07-31 | THC Aug avg: 3.58% median: 7.28% win: 75% σ: 12.85% n: 4 2022-04-12 → 2026-07-31 (current) | THC Sep avg: -3.35% median: -4.25% win: 50% σ: 10.96% n: 4 2022-04-12 → 2026-07-31 | THC Oct avg: -9.38% median: -10.36% win: 25% σ: 8.84% n: 4 2022-04-12 → 2026-07-31 | THC Nov avg: 7.42% median: 4.56% win: 75% σ: 15.25% n: 4 2022-04-12 → 2026-07-31 | THC Dec avg: -1.18% median: -1.35% win: 50% σ: 10.32% n: 4 2022-04-12 → 2026-07-31 |